Gathright, who has been reporting for The Post on contract since May, is a gifted reporter who immediately impressed us with her ability to land scoops.
Editas Medicine (NASDAQ:EDIT – Get Free Report) had its target price decreased by equities research analysts at Wells Fargo & Company from $9.00 to $7.00 in a report issued on Tuesday, Benzinga ...